Dr. Ning is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030Phone+1 713-792-6161
Education & Training
- University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 2016 - 2020
- University of Texas Health Science Center (UT Health)MPH, Healthcare Management, Delta Omega Honorary Society, 2018 - 2019
- MedStar Health/Georgetown-Washington Hospital CenterInternship, Internal Medicine, 2015 - 2016
- Vanderbilt University School of MedicineClass of 2015, MD
- Virginia Polytechnic Institute and State University (Virginia Tech)BS, Biochemistry, Outstanding Graduating Senior of the College of Science, 2007 - 2011
Certifications & Licensure
- FL State Medical License 2021 - Present
- AZ State Medical License 2022 - 2026
- MS State Medical License 2022 - 2025
- TN State Medical License 2022 - 2025
- TX State Medical License 2020 - 2025
- WA State Medical License 2022 - 2025
- AL State Medical License 2023 - 2024
- American Board of Radiology Radiation Oncology
- Join now to see all
Publications & Presentations
PubMed
- 10 citationsLow-dose radiation (4 Gy) with/without concurrent chemotherapy is highly effective for relapsed, refractory mantle cell lymphomaMatthew S. Ning, Chelsea C. Pinnix, Bhavana V. Chapman, Jillian R. Gunther, Sarah A. Milgrom
Blood Advances. 2019-07-09 - 50 citationsIncidence and Predictors of Pericardial Effusion After Chemoradiation Therapy for Locally Advanced Non-Small Cell Lung Cancer.Matthew S. Ning, L. Tang, Daniel R. Gomez, Ting Xu, Yangkun Luo
International Journal of Radiation Oncology, Biology, Physics. 2017-09-01 - 123 citationsStereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecif...Joe Y. Chang, Reza J. Mehran, Lei Feng, Vivek Verma, Zhongxing Liao
The Lancet. Oncology. 2021-10-01
Authored Content
- Cost Analysis of PET/CT vs. CT as Surveillance for Stage III Non-Small Cell Lung Cancer After Definitive Radiation TherapyMarch 2018
Press Mentions
- Low-Dose Radiation Effective With/Without Concurrent Chemotherapy in R/R Mantle Cell LymphomaSeptember 5th, 2019
External Links
- MD Anderson Faculty Profilehttps://faculty.mdanderson.org/profiles/matthew_ning.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: